CD4 regulatory T cells Control CD8 T cell responses to human Herpesvirus 8 lytic and latency proteins
Infectious Agents and Cancer volume 7, Article number: O17 (2012)
CD8 T cells are considered to play an important role in controlling human herpesvirus 8 (HHV-8/KSHV) infection. However, these T cell responses are non-robust compared to other herpesviruses, suggesting that they are under tight regulatory control.
Longitudinal PBMC samples were obtained from subjects with various outcomes of HHV-8 infection over many years in the Multicenter AIDS Cohort Study. The PBMC were tested by HLA A*0201 multimer staining specific for memory CD8 T cell epitopes of viral lytic and latency proteins, and polyfunctional flow cytometry to detect HHV8-specific, polyfunctional CD8 T cell populations. The effect of Treg was examined by depleting CD4+CD25Hi cells.
Direct staining of PBMC with multimer MHC I complexes showed a relatively high frequency of circulating, HHV-8 lytic and latency antigen-specific CD8 T cells, but low anti-HHV-8 T cell polyfunctional reactivity. Removal of Treg enhanced T cell responses to these HHV-8 epitopes. The frequency of T cells specific for HHV-8 lytic antigens was greater than for latent antigens, and this effect was greater when Treg were removed. Numbers of HHV-8 specific effector memory CD8 T cells increased and terminally differentiated memory CD8 T cells decreased over many years of HHV-8 infection. We are currently assessing anti-HHV-8 T cell and Treg activity in relation to development of KS.
We show for the first time that Treg suppress CD8 T cell responses to HHV-8 lytic and latency antigens, effectively masking more robust, underlying anti-HHV-8 T cell responses. The involvement of CD8 T cells and Treg in control of HHV-8 infection has important implications for development of vaccines to prevent KS.
About this article
Cite this article
Lepone, L., Rappocciolo, G., Piazza, P. et al. CD4 regulatory T cells Control CD8 T cell responses to human Herpesvirus 8 lytic and latency proteins. Infect Agents Cancer 7 (Suppl 1), O17 (2012). https://doi.org/10.1186/1750-9378-7-S1-O17